---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-091002"
form_type: "8-K"
ticker: "TTRX"
cik: "0002023016"
company_name: "Turn Therapeutics Inc."
filed_at: "2026-08-18T12:30:15+00:00"
generated_at: "2026-08-18T12:35:18.577514+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Turn Therapeutics issues 579,664 shares to GEM on cashless warrant exercise

## Summary
- On Aug 13, 2026, GEM exercised warrant in full via cashless provision; company issued 579,664 common shares.
- Warrant originally covered 1,192,207 shares (4% fully diluted) at $5.03 exercise price, dated Oct 8, 2025.
- Shares issued under Section 4(a)(2) exemption; GEM represented as accredited investor.
- Exercise triggered because per-share market value exceeded $5.03 warrant price.
- No new capital raised; dilution of ~0.5% of fully diluted shares (579,664 vs. prior total).

## SEC filing metadata
- accession: 0001213900-26-091002
- form_type: 8-K
- ticker: TTRX
- cik: 0002023016
- company_name: Turn Therapeutics Inc.
- filed_at: 2026-08-18T12:30:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/0001213900-26-091002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/ea0302512-8k_turn.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-091002
- JSON: https://secwatch.observer/filing/0001213900-26-091002.json
- Plain text: https://secwatch.observer/filing/0001213900-26-091002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.